Rapimig (zolmitriptan) tablets 2,5 mg. #2

$0.00

Manufactured in: Malta

Rapimig tablets are used to treat migraine attacks in adults by narrowing blood vessels in the brain to relieve symptoms like headache, nausea, and sensitivity to light and sound. The recommended dose is 2 tablets at onset, with a maximum of 10 mg.

Out of stock

SKU: MED7409 Category:

Description

Rapimig (zolmitriptan) Dispersible Tablets 2.5 mg.

Rapimig is a medication that comes in the form of dispersible tablets containing 2.5 mg. of zolmitriptan. Zolmitriptan is a selective serotonin receptor agonist used to treat migraine headaches. This medication is available in packs containing 2 tablets.

What is Rapimig (Zolmitriptan)?

Rapimig is a prescription medication that belongs to a class of drugs known as triptans. Zolmitriptan works by narrowing blood vessels in the brain to reduce pain and other symptoms associated with migraines, such as headache, nausea, sensitivity to light, and sound.

Indications and Usage

Rapimig dispersible tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. It should not be used to prevent migraines or to treat other types of headaches.

Dosage and Administration

The recommended dose of Rapimig is 2.5 mg. taken orally at the onset of a migraine headache. The tablet should be dispersed in a glass of water before swallowing. If the migraine symptoms do not improve after the initial dose, a second tablet can be taken after at least 2 hours. The maximum dose in a 24-hour period should not exceed 10 mg.

Contraindications

Rapimig is contraindicated in patients with a history of heart disease, uncontrolled high blood pressure, stroke, or peripheral vascular disease. It should not be used in patients with hemiplegic or basilar migraine, or in combination with other serotonin receptor agonists or monoamine oxidase inhibitors.

Warnings and Precautions

Before taking Rapimig, inform your healthcare provider if you have any allergies, liver or kidney disease, or risk factors for heart disease. This medication may cause dizziness or drowsiness, so avoid driving or operating heavy machinery until you know how it affects you. If you experience chest pain, shortness of breath, or changes in vision while taking Rapimig, seek immediate medical attention.

Adverse Reactions

Common side effects of Rapimig may include dizziness, drowsiness, dry mouth, nausea, or fatigue. Rare but serious side effects may include chest pain, irregular heartbeat, or signs of a stroke. If you experience any unusual symptoms while taking Rapimig, contact your healthcare provider immediately.

Drug Interactions

Rapimig may interact with other medications, including antidepressants, antipsychotics, or other migraine medications. Inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, supplements, and herbal products, to avoid potential drug interactions.

Storage

Store Rapimig dispersible tablets at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Do not use Rapimig after the expiration date printed on the packaging.

Conclusion

Rapimig (zolmitriptan) dispersible tablets 2.5 mg. are an effective medication for the treatment of acute migraine attacks in adults. When used as directed, Rapimig can help alleviate migraine symptoms and improve the quality of life for individuals suffering from this debilitating condition. It is important to follow the dosage instructions, adhere to contraindications, and be aware of potential side effects to ensure the safe and effective use of Rapimig.